Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis

Published:2024-01 Issue: Volume:119 Page:109-117
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Paolillo Stefania^ORCID,Basile Christian^ORCID,Dell'Aversana Simona,Esposito Immacolata,Chirico Alfonsina,Colella Angela^ORCID,Esposito Gennaro^ORCID,Santo Mariafrancesca Di,Fierro Maria Francesca,Carbone Francesca^ORCID,Marzano Federica,Amato Chiara,Gargiulo Paola,Perrone Filardi Pasquale

Publisher

Elsevier BV

Subject

Internal Medicine

Reference24 articles.

1. Predictors of hyperkalemia and death in patients with cardiac and renal disease;Jain;Am J Cardiol,2012

2. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology

3. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews;Page;BMJ,2021

4. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-an overview in the context of health decision-making;Brozek;J Clin Epidemiol,2021

5. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range;Luo;Stat Methods Med Res,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Heart Failure in Chronic Kidney Disease: A Review of Current Literature;Current Treatment Options in Cardiovascular Medicine;2024-07-02

2. Novel Potassium Binders for CKD Patients with Hyperkalemia;Chronic Kidney Disease - Novel Insights into Pathophysiology and Treatment;2024-04-15